In 2024, the Central Drugs Standard Control Organization (CDSCO), Govt. of India, has approved the commercial production of Lumpi-ProVacInd by Biovet Pvt Ltd, Bengaluru. Previously, in 2021, India authorized a goatpox (heterologous) vaccine against LSDV in cattle.

Vaccinated cows that develop an antibody response will confer maternal immunity to lumpy skin disease by means of colostrum and this last for 4 to 6 months. Maternal antibodies in calves may have an influence on the vaccine efficacy. Only healthy …

2023年1月1日 · Lumpi-ProVac is safe in animals and induces LSDV-specific antibody-and cell-mediated immune response, besides providing complete protection against lethal LSDV challenge. The vaccine is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year.

2022年12月31日 · Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year. A single dose of the vaccine contains 103.5 TCID50 of live-attenuated LSDV (Ranchi strain). The vaccine is stored at 4°C.

Pregnant cows may be vaccinated with LumpyVax®. A booster vaccination should be given annually. Immunity starts to develop about 10 days after immunisation and animals should be …

For the prophylactic immunisation of cattle against lumpy skin disease.

Large-scale regional vaccination of cattle and Asian water buffalos (Bubalus bubalis) is the most effective tool to halt the spread of lumpy skin disease (LSD) and to minimize cattle production losses caused by outbreaks [1].

2023年5月26日 · It was India’s first (indigenous) homologous live-attenuated lumpy skin disease (LSD) vaccine made by using a local LSD virus strain from Ranchi. The technology was released by the Union Agriculture Minister Narendra Singh Tomar and Union Animal Husbandry and Dairying Minister Parshottam Rupala on August 10, 2022.

2022年8月10日 · Providing a big relief to the livestock of the country, the Union Minister for Agriculture and Farmers Welfare, Shri Narendra Singh Tomar, today launched the indigenous vaccine Lumpi-ProVac Ind to protect livestock from Lumpy Skin disease. The vaccine has been developed by the National Equine Research Center, Hisar (Haryana) in collaboration ...

2022年12月31日 · Lumpi-ProVac is safe in animals and induces LSDV-specific antibody-and cell-mediated immune response, besides providing complete protection against lethal LSDV challenge. The vaccine is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year.